Company Data
Pulse Biosciences Inc
Ticker
PLSE
Current Price
$20 -1.33%
Market Cap
$1.2B
Price Target
Refer to Report
Volume
119.1K
52wk Range
$6.595 - $25
Overview
Pulse Biosciences Inc is a United States based clinical stage medical therapy company which pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage.